louisakewell, Author at European Medical Journal - Page 102 of 153

Continue
EMJ
13th August 2015

The management of breast cancer in the Japanese population

At the 14th St. Gallen International Breast Cancer Conference 2015, Masakazu Toi, MD, PhD, of Kyoto University, Japan, explains that there are still only…
13th August 2015

New therapeutic approaches for Hodgkin lymphoma

At the 20th Congress of the European Hematology Association (EHA), Andrew Davies, BSc (Hons), BM (Hons), MRCP, PhD, of the University of Southampton…
13th August 2015

Novel monoclonal antibody-based therapies for multiple myeloma

At the 20th Congress of the European Hematology Association (EHA), Sagar Lonial, MD, of the Winship Cancer Institute, Emory University, Atlanta, GA…
EMJ
13th August 2015

Borealis-1™: Phase 2 trial of gemcitabine/cisplatin plus apatorsen in advanced bladder cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sumanta K. Pal, MD, of City of Hope Comprehensive Cancer Center, Duarte, CA…
EMJ
1 Mins
10th August 2015

Women Who Suffer Stillbirths Are More Likely to Have Another

WOMEN are up to four-times more likely to experience stillbirth if they have had a stillbirth in a previous pregnancy. Poor fetal growth, placental…
EMJ
1 Mins
10th August 2015

Study of Cholesterol in Cells Sheds Light on Infertility and Puberty

KEY molecule that controls the trafficking of cholesterol inside cells affects their ability to produce steroid hormones that support pregnancy…
EMJ
1 Mins
3rd August 2015

‘Artificial Pancreas’ Could Revolutionise Control of Type 1 Diabetes

IMPLANTABLE ‘artificial pancreas’ may eliminate the use of insulin injections and pumps for individuals with Type 1 diabetes (T1D), potentially…
EMJ
1 Mins
3rd August 2015

Genetic Variation Affects Potency of Anti-Diabetic Drug

EFFECTIVENESS of an anti-diabetic drug depends on small, natural differences in DNA among individuals, a discovery that has paved the way…
28th July 2015

IL-17 Inhibition: Emerging Perspectives in the Future Management of Axial Spondyloarthritis

The meeting was opened by Prof Atul Deodhar who introduced the prevalence, epidemiology, and clinical features of axial spondyloarthritis (axSpA), and…
28th July 2015

IL-17 Inhibition in Spondyloarthritis: A Targeted Approach in Psoriatic Arthritis

Prof Philip Mease introduced psoriatic arthritis (PsA) with a particular emphasis on disease symptoms and an update on the status of current disease…